首页> 外国专利> INDOLINONA COMBINATORY LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASES.

INDOLINONA COMBINATORY LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASES.

机译:印第安纳州联合图书馆和相关产品以及治疗疾病的方法。

摘要

THE PRESENT INVENTION REFERS TO ORGANIC MOLECULES, ABLE TO MODULATE, REGULATE AND / OR INHIBIT THE TRANSDUCTION OF THE PROTEIN KINASE SIGNAL. THESE COMPOUNDS ARE USEFUL FOR THE TREATMENT OF DISEASES RELATED TO THE TRANSDUCTION OF THE SIGN OF THE PROTEIN QUINASA NOT REGULATED, INCLUDING CELLULAR PROLIFERATION DISEASES AS CANCER, ARTERIOSCLEROSIS, ARTHRITIS AND RESTENOSES, METHODSET. THE INVENTION DESCRIBES INDOLINONE COMPOUNDS THAT POTENTLY INHIBIT THE PROTEIN KINASES, AS WELL AS RELATED PRODUCTS AND PROCEDURES. SPECIFIC INHIBITORS CAN BE OBTAINED FOR THE FLK KINASE PROTEIN, BY ADDING CHEMICAL SUBSTITUTES TO 3 - [(INDOL 3 - IL) METHYLENE] - 2 - INDOLINONE, ESPECIALLY IN THE 1 '' POSITION OF THE INDOL RING. INDOLINONE COMPOUNDS THAT SPECIFICALLY INHIBIT THE FLK KINASE PROTEIN AND THE GROWTH FACTOR DERIVED FROM PLATES, CAN HAVE A TETRAHYDROINDOL OR CYCLOPENTANE FRACTION - B - PIRROL. INDOLINONE COMPOUNDS THAT ARE MODIFIED BY SUBSTITUTES, ESPECIALLY IN POSITION 5 OF THE OXINDOL RING, CAN ACTIVATE THE PROTEIN KINASES EFFECTIVELY. THE INVENTION ALSO DESCRIBES NEW HYDROSOLUBLE INDOLINONE COMPOUNDS THAT ARE INHIBITORS OF THYROSINE KINASE, AS WELL AS RELATED PRODUCTS AND PROCEDURES.
机译:本发明涉及有机分子,其能够调节,调节和/或抑制蛋白质激酶信号的传递。这些化合物可用于治疗与不规范蛋白质Quinosa迹象有关的疾病,包括细胞增殖性疾病,如癌症,动脉硬化,关节炎和残留物,方法集。本发明描述了有效抑制蛋白激酶的吲哚啉酮化合物以及相关产品和方法。通过将化学取代物添加到3-[(吲哚3-IL)亚甲基] -2-吲哚啉酮中,特别是在吲哚环的1英寸位置,可以获得FLK激酶蛋白的特定抑制剂。吲哚啉酮化合物特别抑制FLK激酶蛋白和来自板的生长因子,可能具有四氢吲哚或环戊烷馏分-B-PIRROL。通过取代基修饰的吲哚酮化合物(尤其是在OXINDOL环的5位上)可以有效激活蛋白激酶。本发明还描述了作为酪氨酸激酶抑制剂的新的水溶性吲哚啉酮化合物,以及相关产品和方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号